1. Percutaneous transluminal angioplasty and stenting in acute stroke caused by basilar artery steno-occlusive disease: The experience of a single stroke centre
- Author
-
João Gilberto Mendes dos Reis, Alberto Fior, Ana Paiva Nunes, Gonçalo Borges de Almeida, Isabel Fragata, Marta Sequeira, Manuel Machado, Filipa Pedro, and Rui A. Carvalho
- Subjects
Male ,medicine.medical_specialty ,Percutaneous ,medicine.medical_treatment ,Occlusive disease ,Arterial Occlusive Diseases ,Constriction, Pathologic ,Transluminal Angioplasty ,Internal medicine ,medicine.artery ,medicine ,Basilar artery ,Vertebrobasilar Insufficiency ,Humans ,Stroke ,Acute stroke ,Aged ,business.industry ,Basilar artery occlusion ,Angioplasty ,Stent ,General Medicine ,medicine.disease ,Treatment Outcome ,Basilar Artery ,Cardiology ,Female ,Stents ,business - Abstract
Background Percutaneous transluminal angioplasty and stenting in acute stroke due to severe basilar artery stenosis or basilar artery occlusion remain a matter of debate. The higher risk of stroke recurrence in patients with vertebrobasilar stenosis compared to anterior circulation atherosclerotic disease creates high expectations concerning endovascular approaches. This study aims to review our experience with percutaneous transluminal angioplasty and stenting in acute stroke caused by basilar artery steno-occlusive disease. Methods Our prospective database from June 2014 until December 2020 was screened and patients with acutely symptomatic severe (>80%) basilar artery stenosis or acute basilar artery occlusion who underwent percutaneous transluminal angioplasty and stenting were analysed. Results Twenty-five patients included: 72% men (mean age 68.6 years), all with prior modified Rankin Scale Conclusions Percutaneous transluminal angioplasty and stenting showed to be a technically feasible and reasonably safe procedure in selected patients. However, good clinical outcomes may be difficult to achieve as only 43.5% of the patients remained independent at 3 months. Randomized studies are needed to confirm the efficacy and safety outcomes of percutaneous transluminal angioplasty and stenting in acute stroke caused by basilar artery steno-occlusive disease.
- Published
- 2023